Longitudinal Improvements in Symptom Burden Among Oncology Patients Enrolled in Reimagine Care, a Virtual Care Platform: A Retrospective Study (Preprint)
JMIR Cancer · 2026
DOI: 10.2196/107798 ↗Kurz gefasst
Fachartikel in der Zeitschrift JMIR Cancer, 2026. Verfasst von Courtney Jewell und 4 weiteren Autor:innen. Beteiligte Einrichtung: Fit Minded Inc, 2901 E Greenway Road, PO Box 30271, Phoenix, AZ, 85046, United States. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Symptom burden during active cancer treatment is prevalent and clinically significant, yet it frequently goes unmonitored between scheduled care visits. Virtual care platforms offer a promising approach to continuous real-world symptom management, though longitudinal evidence in these settings remains limited. The aims of this study were as follows: (1) characterize the demographic and clinical profile of enrolled patients and their baseline symptom burden, (2) estimate population-level symptom trajectories over 180 days, and (3) examine whether platform engagement and cancer-related characteristics moderated symptom change over time. This retrospective study analyzed secondary data from 2214 oncology patients enrolled in Reimagine Care between December 2022 and May 2026. Symptom burden was assessed using an adapted version of the Edmonton Symptom Assessment System (ESAS; 10 items, 11-point scale), administered via electronic patient-reported outcome surveys. Longitudinal trajectories were estimated using linear mixed-effects models with repeated electronic patient-reported outcome observations nested within patients over 180 days. Moderation by virtual care center engagement intensity and metastatic disease status was examined using time-by-moderator interaction terms. The analytic cohort had a mean age of 63.7 (SD 12.9) years, was predominantly female patients (1304/2214, 58.9%), with a mean of 4.22 (SD 4.19) noncancer comorbidities. Breast cancer was the most prevalent diagnosis (630/2214, 28.5%), and 25.3% (561/2214) had documented metastatic disease. Tiredness was the most severe symptom at baseline (mean 4.21, SD 2.85). Total symptom burden declined significantly over 180 days (β=-0.0236, P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Fit Minded Inc, 2901 E Greenway Road, PO Box 30271, Phoenix, AZ, 85046, United States.
Zitieren
APA
Jewell, C., McAlister, K., Huffman, L., Knight, E., & Huberty, J. (2026). Longitudinal Improvements in Symptom Burden Among Oncology Patients Enrolled in Reimagine Care, a Virtual Care Platform: A Retrospective Study (Preprint). JMIR Cancer. https://doi.org/10.2196/107798
Vancouver
Jewell C, McAlister K, Huffman L, Knight E, Huberty J. Longitudinal Improvements in Symptom Burden Among Oncology Patients Enrolled in Reimagine Care, a Virtual Care Platform: A Retrospective Study (Preprint). JMIR Cancer. 2026. doi:10.2196/107798
BibTeX
@article{Jewell2026,
author = {Jewell, Courtney and McAlister, Kelsey and Huffman, Landry and Knight, Elizabeth and Huberty, Jennifer},
title = {Longitudinal Improvements in Symptom Burden Among Oncology Patients Enrolled in Reimagine Care, a Virtual Care Platform: A Retrospective Study (Preprint)},
journal = {JMIR Cancer},
year = {2026},
doi = {10.2196/107798}
}
EUVIMED